(Q40002240)

16 September 2017

1 reference

title

The development of hemostasis in the human fetus and newborn infant (English)

1 reference

16 September 2017

Bleyer WA

1

1 reference

16 September 2017

Hakami N

series ordinal

2

1 reference

16 September 2017

Shepard TH

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 November 1971

1 reference

The Journal of Pediatrics

16 September 2017

1 reference

16 September 2017

79

1 reference

16 September 2017

838-853

1 reference

16 September 2017

5

1 reference

The causes of neonatal mortality: an analysis of 501 autopsies on newborn infants.

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Coagulation changes in the neonatal period and in early infancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Placental barrier to coagulation factors: its relevance to the coagulation defect at birth and to haemorrhage in the newborn.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

THE PLASMA CONCENTRATION OF FACTOR VIII IN THE NORMAL POPULATION. I. MOTHERS AND BABIES AT BIRTH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Origin of megakaryocyte granules from Golgi vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Human bone marrow during the last three months of intrauterine life. A histological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Fibrinolysis in human foetuses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

COAGULATION STUDIES WITH FETAL BLOOD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

7 January 2021

Fibrinolysis in newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Effects of maternal thiazides on platelet counts of newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Platelet counts in healthy premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

PLATELET COUNTS IN PREMATURE INFANTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Altered platelet function in newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

FRACTIONATION OF THE SERUM AND PLASMA PROTEINS BY SALT PRECIPITATION IN INFANTS AND CHILDREN. 1. THE CHANGES WITH MATURITY AND AGE. 2. THE CHANGES IN GLOMERULONEPHRITIS. 3. THE CHANGES IN NEPHROSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Changes in fibrin-stabilizing factor levels in relation to maternal hemorrhage and neonatal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

[Fetal fibrinogen. II. Studies on the fibrinolytic resistance of "umbilical vein fibrin"].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

[Fetal fibrinogen. III. Research on the thrombin sensitivity of fibrinogen in newborn]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Diagnosis and management of disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Fibrinolytic activity in premature infants. Relationship of the enzyme system to the respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Hypoprothrombinaemia in the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Classification of the hypoprothrombinemias based on the state of prothrombin in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

The hageman factor: determinations of its concentration during the neonatal period and presentation of a case of hageman factor deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

PLASMA THROMBOPLASTIN ANTECEDENT (FACTOR XI) IN THE NEONATE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Christmas-factor activity of cord blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Changes in blood coagulation factors during the first week of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Behaviour of factor VII and prothrombin in late pregnancy and in the newborn.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Prothrombin and proconvertin in the newborn and during the first year of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

ELEVATION OF FACTOR VIII (ANTIHEMOPHILIC FACTOR) DURING PREGNANCY IN NORMAL PERSONS AND IN A PATIENT WITH VON WILLEBRAND'S DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

ON THE PHYSIOLOGY OF BLOOD COAGULATION IN THE NEWBORN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

FETAL FIBRINOGEN. IV. STUDIES ON THE IMMUNOLOGICAL AND PHYSICO-CHEMICAL BEHAVIOR OF FETAL FIBRINOGEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

Isolation and characterization of fetal fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2871%2980405-5

10.1016/S0022-3476(71)80405-5

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference